On June 11, 2009, we hired Robert Dickey IV as a Senior Vice President.
Mr. Dickey, age 53, combines over 12 years of experience in biotech senior
management following an 18 year career as an investment banker. Mr. Dickey has
been a consultant to Hemispherx since November, 2008. Previously, he had been
involved in three biotech companies holding positions including CFO, COO, CEO
and board member. From 2007 through October, 2008, Mr. Dickey was Senior Vice
President, CFO and Business Unit Manager for StemCyte, Inc., an umbilical cord
stem cell therapeutics company. From 2005 to 2007, he was Vice President,
Finance and CFO of Locus Pharmaceuticals, Inc., a company involved in the use of
supercomputers to design drugs. From 2003 to 2005, he was President and Chief
Executive Officer of Protarga, Inc., a cancer company with a compound in Phase
III development. Mr. Dickey has been a member of the Board of Directors of
Protarga since 1996.
He has an undergraduate degree from Princeton University and an MBA from the
Wharton School of the University of Pennsylvania.
Pursuant to his employment agreement, Mr. Dickey is employed as our Senior Vice
President. He will receive an annual salary at the rate of $275,000 per year and
will be entitled to annual bonuses in the discretion of our Board of Directors
of up to 25% of his annual salary. Mr. Dickey will receive four year options to
purchase up to 150,000 shares of our common stock at an exercise price of $2.81
per shares.